Health Catalyst (Health Catalyst) Debt-to-Equity : 0.68 (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Health Catalyst Debt-to-Equity?

Health Catalyst's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $3.4 Mil. Health Catalyst's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $245.7 Mil. Health Catalyst's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $366.9 Mil. Health Catalyst's debt to equity for the quarter that ended in Dec. 2023 was 0.68.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Health Catalyst's Debt-to-Equity or its related term are showing as below:

HCAT' s Debt-to-Equity Range Over the Past 10 Years
Min: -0.07 Med: 0.39 Max: 0.71
Current: 0.68

During the past 7 years, the highest Debt-to-Equity Ratio of Health Catalyst was 0.71. The lowest was -0.07. And the median was 0.39.

HCAT's Debt-to-Equity is ranked worse than
61.24% of 547 companies
in the Healthcare Providers & Services industry
Industry Median: 0.46 vs HCAT: 0.68

Health Catalyst Debt-to-Equity Historical Data

The historical data trend for Health Catalyst's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Health Catalyst Debt-to-Equity Chart

Health Catalyst Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.26

0.71

0.39

0.58

0.68

Health Catalyst Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial															0.58	0.61	0.64	0.65	0.68

Competitive Comparison of Health Catalyst's Debt-to-Equity

For the Health Information Services subindustry, Health Catalyst's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Health Catalyst's Debt-to-Equity Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Health Catalyst's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Health Catalyst's Debt-to-Equity falls into.

Health Catalyst Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Health Catalyst's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(3.358	+	245.71)	/	366.919
	=	0.68

Health Catalyst's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(3.358	+	245.71)	/	366.919
	=	0.68

Health Catalyst (NAS:HCAT) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Health Catalyst Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Health Catalyst's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Health Catalyst (Health Catalyst) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Health Catalyst Inc (NAS:HCAT) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

2YP:Germany

Address

10897 South River Front Parkway, Suite 300, South Jordan, UT, USA, 84095

Website

https://www.healthcatalyst.com

Health Catalyst Inc is engaged in providing data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, which is the key revenue driver, includes data platform, analytics applications and support services. This generates revenues primarily from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; and Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsource, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.

Executives

Linda Llewelyn	officer: Chief People Officer	C/O HEALTH CATALYST, INC., 3165 E. MILLROCK DRIVE #400, SALT LAKE CITY UT 84121
Jason Alger	officer: Chief Accounting Officer	C/O HEALTH CATALYST, 3165 MILLROCK DR #400, SALT LAKE CITY UT 84121
Benjamin Landry	officer: General Counsel	C/O HEALTH CATALYST, INC., 10897 SOUTH RIVER FRONT PARKWAY #300, SOUTH JORDAN UT 84095
Matthew Kolb	director	C/O HEALTH CATALYST, INC., 10897 SOUTH RIVER FRONT PARKWAY #300, SOUTH JORDAN UT 84095
Bryan Truman Hunt	officer: Chief Financial Officer	C/O HEALTH CATALYST, 3165 MILLROCK DR #400, SALT LAKE CITY UT 84121
Daniel D. Burton	director, officer: Chief Executive Officer	C/O HEALTH CATALYST, INC., 3165 E. MILLROCK DRIVE #400, SALT LAKE CITY UT 84121
Anne Marie Bickmore	officer: COO and Chief Product Officer	C/O HEALTH CATALYST, INC., 10897 SOUTH RIVER FRONT PARKWAY #300, SOUTH JORDAN UT 84095
Kevin Lee Freeman	officer: Chief Growth Officer	C/O HEALTH CATALYST, INC., 10897 SOUTH RIVER FRONT PARKWAY #300, SOUTH JORDAN UT 84095
Daniel H. Orenstein	officer: General Counsel	311 ARSENAL STREET, WATERTOWN MA 02472
Duncan Gallagher	director	C/O HEALTH CATALYST, INC., 3165 E. MILLROCK DRIVE #400, SALT LAKE CITY UT 84121
Paul Horstmeier	officer: Chief Operating Officer	C/O HEALTH CATALYST, INC., 3165 E. MILLROCK DRIVE #400, SALT LAKE CITY UT 84121
Bryan Richard Hinton	officer: Chief Technology Officer	C/O HEALTH CATALYST, 10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN UT 84095
Nelli James Patrick Jr.	officer: Chief Financial Officer	C/O HEALTH CATALYST, INC., 3165 E.MILLROCK DRIVE #400, SALT LAKE CITY UT 84121
Anita Pramoda	director	222 MERCHANDISE MART PLAZA, SUITE 2024, CHICAGO IL 60654
Timothy G. Ferris	director	C/O HEALTH CATALYST, INC., 3165 E. MILLROCK DRIVE, #400, SALT LAKE CITY UT 84121